Sourcing human embryos for embryonic stem cell lines: problems & perspectives

Area of Science:

• Stem Cell Biology
• Developmental Biology
• Regenerative Medicine
• In Vitro Fertilization (IVF)

Background:

• Human embryonic stem cells (hESC) derived from IVF embryos hold significant potential for understanding human development and advancing regenerative medicine.
• Current sources of embryos for hESC derivation are typically 'spare' or 'discarded' embryos from IVF procedures.
• Ethical considerations arise regarding embryo procurement, including potential overstimulation for egg retrieval and the fate of morphologically abnormal embryos.

Purpose of the Study:

• To discuss novel methods for procuring embryos for embryonic stem cell line derivation.
• To address ethical concerns associated with embryo sourcing for stem cell research.
• To explore the potential use of stem cells derived from morphologically abnormal embryos.

Main Methods:

• Review of current practices in embryo procurement for hESC derivation.
• Discussion of ethical debates surrounding embryo sourcing and quality assessment.
• Exploration of newer methods for embryo procurement that balance ethical considerations with the need for source material.

Main Results:

• Embryo quality assessment is currently subjective, relying primarily on morphology and developmental rate.
• Ethical questions persist regarding the stimulation of women for extra eggs and the discarding of embryos.
• The paper proposes newer methods to ethically source embryos for hESC derivation.

Conclusions:

• There is a need for improved, objective criteria for embryo assessment to guide decisions on discarding embryos.
• Newer procurement methods are being explored to ethically source embryos for hESC derivation, including those with suboptimal morphology.
• Advancing regenerative medicine requires innovative approaches to stem cell sourcing while respecting ethical boundaries.